[Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
Using the method of double-blind trial the effectiveness of treatment with Anginin (pyrridinolcarbamate) and Stugeron (cinnarizine) was evaluated. The somatic and mental condition and the results of motor rehabilitation of the patients were estimated. In all the evaluated elements the results of Stugeron treatment were better. The results were assessed in two groups of 20 cases each of patients with cerebral atherosclerosis observed during two months.
D000328:Adult; D000368:Aged; D002219:Carbamates / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002936:Cinnarizine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011727:Pyridinolcarbamate / Q000627:therapeutic use*
D002219:Carbamates; D010879:Piperazines; D002936:Cinnarizine; D011727:Pyridinolcarbamate
Porównanie skuteczności leczenia anginina i stugeronem w miazdzycy naczyń mózgowych.